345 related articles for article (PubMed ID: 31816062)
1. Genomic analyses of flow-sorted Hodgkin Reed-Sternberg cells reveal complementary mechanisms of immune evasion.
Wienand K; Chapuy B; Stewart C; Dunford AJ; Wu D; Kim J; Kamburov A; Wood TR; Cader FZ; Ducar MD; Thorner AR; Nag A; Heubeck AT; Buonopane MJ; Redd RA; Bojarczuk K; Lawton LN; Armand P; Rodig SJ; Fromm JR; Getz G; Shipp MA
Blood Adv; 2019 Dec; 3(23):4065-4080. PubMed ID: 31816062
[TBL] [Abstract][Full Text] [Related]
2. Genomic analyses of PMBL reveal new drivers and mechanisms of sensitivity to PD-1 blockade.
Chapuy B; Stewart C; Dunford AJ; Kim J; Wienand K; Kamburov A; Griffin GK; Chen PH; Lako A; Redd RA; Cote CM; Ducar MD; Thorner AR; Rodig SJ; Getz G; Shipp MA
Blood; 2019 Dec; 134(26):2369-2382. PubMed ID: 31697821
[TBL] [Abstract][Full Text] [Related]
3. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
Liu WR; Shipp MA
Blood; 2017 Nov; 130(21):2265-2270. PubMed ID: 29167175
[TBL] [Abstract][Full Text] [Related]
4. Mass cytometry of Hodgkin lymphoma reveals a CD4
Cader FZ; Schackmann RCJ; Hu X; Wienand K; Redd R; Chapuy B; Ouyang J; Paul N; Gjini E; Lipschitz M; Armand P; Wu D; Fromm JR; Neuberg D; Liu XS; Rodig SJ; Shipp MA
Blood; 2018 Aug; 132(8):825-836. PubMed ID: 29880615
[TBL] [Abstract][Full Text] [Related]
5. PD-L1 and PD-L2 Genetic Alterations Define Classical Hodgkin Lymphoma and Predict Outcome.
Roemer MG; Advani RH; Ligon AH; Natkunam Y; Redd RA; Homer H; Connelly CF; Sun HH; Daadi SE; Freeman GJ; Armand P; Chapuy B; de Jong D; Hoppe RT; Neuberg DS; Rodig SJ; Shipp MA
J Clin Oncol; 2016 Aug; 34(23):2690-7. PubMed ID: 27069084
[TBL] [Abstract][Full Text] [Related]
6. Signaling pathways and immune evasion mechanisms in classical Hodgkin lymphoma.
Liu WR; Shipp MA
Hematology Am Soc Hematol Educ Program; 2017 Dec; 2017(1):310-316. PubMed ID: 29222272
[TBL] [Abstract][Full Text] [Related]
7. TNFAIP3 (A20) is a tumor suppressor gene in Hodgkin lymphoma and primary mediastinal B cell lymphoma.
Schmitz R; Hansmann ML; Bohle V; Martin-Subero JI; Hartmann S; Mechtersheimer G; Klapper W; Vater I; Giefing M; Gesk S; Stanelle J; Siebert R; Küppers R
J Exp Med; 2009 May; 206(5):981-9. PubMed ID: 19380639
[TBL] [Abstract][Full Text] [Related]
8. Major Histocompatibility Complex Class II and Programmed Death Ligand 1 Expression Predict Outcome After Programmed Death 1 Blockade in Classic Hodgkin Lymphoma.
Roemer MGM; Redd RA; Cader FZ; Pak CJ; Abdelrahman S; Ouyang J; Sasse S; Younes A; Fanale M; Santoro A; Zinzani PL; Timmerman J; Collins GP; Ramchandren R; Cohen JB; De Boer JP; Kuruvilla J; Savage KJ; Trneny M; Ansell S; Kato K; Farsaci B; Sumbul A; Armand P; Neuberg DS; Pinkus GS; Ligon AH; Rodig SJ; Shipp MA
J Clin Oncol; 2018 Apr; 36(10):942-950. PubMed ID: 29394125
[TBL] [Abstract][Full Text] [Related]
9. Novel cell enrichment technique for robust genetic analysis of archival classical Hodgkin lymphoma tissues.
Juskevicius D; Jucker D; Dietsche T; Perrina V; Rufle A; Ruiz C; Dirnhofer S; Tzankov A
Lab Invest; 2018 Nov; 98(11):1487-1499. PubMed ID: 30087457
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical assessment of the diagnostic utility of PD-L1: a preliminary analysis of anti-PD-L1 antibody (SP142) for lymphoproliferative diseases with tumour and non-malignant Hodgkin-Reed-Sternberg (HRS)-like cells.
Sakakibara A; Kohno K; Eladl AE; Klaisuwan T; Ishikawa E; Suzuki Y; Shimada S; Nakaguro M; Shimoyama Y; Takahara T; Kato S; Asano N; Nakamura S; Satou A
Histopathology; 2018 Jun; 72(7):1156-1163. PubMed ID: 29380399
[TBL] [Abstract][Full Text] [Related]
11. [Microenvironment in classical Hodgkin lymphoma].
Mottok A
Pathologe; 2020 May; 41(3):254-260. PubMed ID: 32239325
[TBL] [Abstract][Full Text] [Related]
12. Constitutive AP-1 activity and EBV infection induce PD-L1 in Hodgkin lymphomas and posttransplant lymphoproliferative disorders: implications for targeted therapy.
Green MR; Rodig S; Juszczynski P; Ouyang J; Sinha P; O'Donnell E; Neuberg D; Shipp MA
Clin Cancer Res; 2012 Mar; 18(6):1611-8. PubMed ID: 22271878
[TBL] [Abstract][Full Text] [Related]
13. Flow sorting and exome sequencing reveal the oncogenome of primary Hodgkin and Reed-Sternberg cells.
Reichel J; Chadburn A; Rubinstein PG; Giulino-Roth L; Tam W; Liu Y; Gaiolla R; Eng K; Brody J; Inghirami G; Carlo-Stella C; Santoro A; Rahal D; Totonchy J; Elemento O; Cesarman E; Roshal M
Blood; 2015 Feb; 125(7):1061-72. PubMed ID: 25488972
[TBL] [Abstract][Full Text] [Related]
14. Autocrine LTA signaling drives NF-κB and JAK-STAT activity and myeloid gene expression in Hodgkin lymphoma.
von Hoff L; Kärgel E; Franke V; McShane E; Schulz-Beiss KW; Patone G; Schleussner N; Kolesnichenko M; Hübner N; Daumke O; Selbach M; Akalin A; Mathas S; Scheidereit C
Blood; 2019 Mar; 133(13):1489-1494. PubMed ID: 30696620
[TBL] [Abstract][Full Text] [Related]
15. Mutation analysis of tumor necrosis factor alpha-induced protein 3 gene in Hodgkin lymphoma.
Etzel BM; Gerth M; Chen Y; Wünsche E; Facklam T; Beck JF; Guntinas-Lichius O; Petersen I
Pathol Res Pract; 2017 Mar; 213(3):256-260. PubMed ID: 28189285
[TBL] [Abstract][Full Text] [Related]
16. Molecular biology of Hodgkin lymphoma.
Weniger MA; Küppers R
Leukemia; 2021 Apr; 35(4):968-981. PubMed ID: 33686198
[TBL] [Abstract][Full Text] [Related]
17. Integrative analysis reveals selective 9p24.1 amplification, increased PD-1 ligand expression, and further induction via JAK2 in nodular sclerosing Hodgkin lymphoma and primary mediastinal large B-cell lymphoma.
Green MR; Monti S; Rodig SJ; Juszczynski P; Currie T; O'Donnell E; Chapuy B; Takeyama K; Neuberg D; Golub TR; Kutok JL; Shipp MA
Blood; 2010 Oct; 116(17):3268-77. PubMed ID: 20628145
[TBL] [Abstract][Full Text] [Related]
18. Recurrent somatic loss of TNFRSF14 in classical Hodgkin lymphoma.
Salipante SJ; Adey A; Thomas A; Lee C; Liu YJ; Kumar A; Lewis AP; Wu D; Fromm JR; Shendure J
Genes Chromosomes Cancer; 2016 Mar; 55(3):278-87. PubMed ID: 26650888
[TBL] [Abstract][Full Text] [Related]
19. Classical Hodgkin lymphoma is characterized by recurrent copy number gains of the short arm of chromosome 2.
Joos S; Menz CK; Wrobel G; Siebert R; Gesk S; Ohl S; Mechtersheimer G; Trümper L; Möller P; Lichter P; Barth TF
Blood; 2002 Feb; 99(4):1381-7. PubMed ID: 11830490
[TBL] [Abstract][Full Text] [Related]
20. Hodgkin Lymphoma: A disease shaped by the tumor micro- and macroenvironment.
Masel R; Roche ME; Martinez-Outschoorn U
Best Pract Res Clin Haematol; 2023 Dec; 36(4):101514. PubMed ID: 38092473
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
